Clinical Trials Sponsored by Karos Pharmaceuticals

Total 19672 results

Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
Kuros Biosurgery AG

Withdrawn

Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

Bone Cysts
Kuros Biosurgery AG

Completed

Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting

Tibia Plateau Fractures

Australia, France, Germany, Hungary, Italy, Poland, Spain, Switzerland, United Kingdom
Akros Pharma Inc.

Completed

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Hepatitis C Virus Infection, Response to Therapy of

Puerto Rico
Kuros Biosurgery AG
Kuros BioSciences B.V.; Simplified Clinical Data Systems, LLC

Not yet recruiting

Post Marketing Study of MagnetOs Putty Compared to Demineralized Bone Matrix (DBM) Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion (PROOF)

Degenerative Disc Disease | Spine Fusion

United States
Kars State Hospital

Completed

Dry Needling Treatment in Hemiplegic Shoulder Pain

Shoulder Pain | Myofascial Pain | Hemiplegia

Turkey
Kars State Hospital

Enrolling by invitation

Exercise and Dry Needling Treatment Combination in Nocturnal Calf Cramps

Myofascial Pain Syndrome | Nocturnal Leg Cramps

Turkey
Kars State Hospital

Completed

Effects of the COVID-19 Pandemic on Fibromyalgia Patients

Chronic Low-back Pain | Fibromyalgia

Turkey
Kars State Hospital

Completed

Short Term Effect of Kinesiotaping In Patients With Shoulder Impingement Syndrome

Exercise | Ultrasound | Kinesiotape

Turkey
Karo Pharma AB

Completed

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Onychomycosis

Tunisia
Karo Pharma AB

Completed

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

Chickenpox

Poland
Karo Pharma AB

Completed

Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms

Vulvovaginal Candidiasis

Poland
Karo Pharma AB

Completed

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Plantar Wart | Common Wart

Poland
Karo Pharma AB

Completed

Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Bacterial Vaginosis

Poland
Karo Pharma AB

Completed

Hemoclin Gel for the Treatment of Hemorrhoids

Hemorrhoids Grade I and II

Poland
Kars State Hospital

Completed

Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

Muscle Weakness | Myofascial Pain Syndrome

Turkey
Aros Pharma ApS

Completed

Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid

Pain

Sweden
Karo Bio AB

Terminated

Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care (AKKA)

Heterozygous Familial Hypercholesterolaemia
Kuros Biosurgery AG
Baxter BioScience

Completed

Adjunctive Therapy to Treat Tibial Shaft Fractures (TSF)

Trauma

Bulgaria, Czech Republic, Finland, France, Germany, Hungary, Italy, Romania, Serbia, Slovakia, Slovenia, Switzerland
Kuros Biosurgery AG
Factory CRO; Kuros BioSciences B.V.; The London Clinic

Withdrawn

Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease (PROGRESS)

Degenerative Disc Disease

United Kingdom
Keros Therapeutics, Inc.
IQVIA Biotech

Recruiting

Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis

Myelofibrosis

Australia
Kuros Biosurgery AG
Baxter BioScience

Completed

Safety and Efficacy of I-020502 in Meshed Skin Autografting

Burns

Germany
Akros Pharma Inc.
ICON Clinical Research

Recruiting

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction (POWER-HF)

Chronic Heart Failure

United States
Kartos Therapeutics, Inc.
Telios Pharma, Inc.

Recruiting

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Primary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis

United States, Italy, Serbia, Poland, France, Austria, Bulgaria, Germany, Hungary, Spain
Telios Pharma, Inc.
Kartos Therapeutics, Inc.

Active, not recruiting

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
A & U Tibbia College Karol Bagh

Completed

A Comparative Study of the Effect of Ayurvedic Drugs and Metformin in the Management of Diabetes Mellitus (Type II)

Diabetes Mellitus, Type 2

India
Karus Therapeutics Limited
University College, London

Withdrawn

A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer

Biliary Tract Cancer

United Kingdom
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
BioClin BV
Avania

Recruiting

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Bacterial Vaginoses

Germany
Kars Harakani State Hospital
Ataturk University

Completed

Rotation and Movement System, Postpartum Cesarean Sections (Rotation)

Breast Feeding, Exclusive

Turkey
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee (FACT CLBP 1)

Osteoarthritis | Chronic Low Back Pain

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

Human Immunodeficiency Virus 1

South Africa, Argentina, Brazil, India, Kenya
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Hepatitis C

United States
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, United Kingdom
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Hepatitis C

Belgium, United States, Puerto Rico, Netherlands
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

To Assess the Patients' Ability to Self-Administer Fasinumab (FACT DEVICE)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

HIV Infections | Hepatitis C

France, Spain, United States, Germany
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents (DIONE)

HIV-1 Infection

France, United States, Spain, Ukraine, United Kingdom, Ireland

Clinical Trials Sponsored by Karos Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations